Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2015-03-31 Declaration of Voting R…
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated March 31, 2015, titled "Antal aktier och röster i Orexo" (Number of shares and votes in Orexo). It explicitly states that the total number of shares and votes has changed due to the exercise of stock options. This type of announcement, detailing a change in the total share count, falls under capital structure changes or share issuance notifications. Comparing the definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate fit, as the change resulted from exercising options, which increases the outstanding share count. It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a dividend notice (DIV) or director dealing (DIRS). The document length is short (1717 chars), but it is the primary announcement of the event, not just an announcement *about* another report, so RPA/RNS is less likely than SHA.
2015-03-31 Swedish
Annual Report 2014
Annual Report Classification · 1% confidence The document is titled 'Årsredovisning 2014' (Annual Report 2014) for the company Orexo. It contains a comprehensive overview of the company's business, management commentary, financial statements (income statement, balance sheet, cash flow), notes to the financial statements, and an auditor's report. This structure is characteristic of a full annual report, not an announcement or a summary. FY 2014
2015-03-25 Swedish
Annual Report 2014
Annual Report Classification · 1% confidence The document is explicitly titled 'Annual Report 2014' and contains comprehensive sections including 'Our Company', 'Report on Operations', 'Financial Report 2014' (with consolidated statements and notes), and 'Corporate Governance Report'. It covers the full fiscal year 2014, provides detailed financial performance, and includes the CEO's message and auditor's report. This matches the definition of an Annual Report (10-K). FY 2014
2015-03-25 English
Notice of Annual General Meeting of Orexo
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of Annual General Meeting of Orexo" and details the date, location, procedures for shareholder participation, and the full proposed agenda for the meeting. The agenda items cover standard AGM business such as electing the chairman, approving the annual report, approving financial statements, determining board fees, and voting on various resolutions (remuneration guidelines, share authorizations, incentive programs). This content perfectly matches the definition of materials shared during an Annual General Meeting. Although it mentions the presentation of the annual report (item 8), the document itself is the notice/invitation and proposal list for the meeting, not the full Annual Report (10-K) or a standalone Audit Report (AR). It is not a short announcement of a report release (RPA/RNS) because it contains substantial detail about the proposals being voted upon, which is characteristic of AGM materials.
2015-03-16 English
Kallelse till årsstämma i Orexo
AGM Information Classification · 1% confidence The document is titled "Kallelse till årsstämma i Orexo" (Notice of Annual General Meeting in Orexo) and explicitly calls shareholders to the AGM on a specific date. The content details the required registration process, the proposed agenda (including items like election of board members, approval of financial statements, and remuneration guidelines), and specific proposals to be voted upon at the meeting. This structure and content are characteristic of a notice for an Annual General Meeting (AGM). The relevant code is AGM-R.
2015-03-16 Swedish
Orexo breddar produktsortimentet för Zubsolv® och meddelar listning av ett nytt godkänt patent i USA
Regulatory Filings Classification · 1% confidence The document is titled "Pressmeddelande" (Press Release) and announces two key events: the launch of a new higher strength tablet for Zubsolv® and the issuance of a new approved patent in the USA (FDA registration). It also mentions the final approval of the REMS plan. This type of announcement, detailing product updates, regulatory milestones (patent approval), and commercial progress, is typically classified as a general regulatory announcement or a specific update that doesn't fit neatly into the core financial reports (10-K, IR, ER). Since it is a specific announcement about regulatory/product progress rather than a change in management (MANG), a financing event (CAP), or a dividend (DIV), and it is not a full financial report, it best fits the general regulatory filing category, RNS, which serves as a fallback for miscellaneous regulatory announcements. Given the short length (3516 chars) and the nature of the announcement, it is not a comprehensive report like an IR or 10-K.
2015-02-17 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.